Ishan Drugs & Pharma Private Limited - Company Profile

It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2019.
2019 New Delhi, Delhi, India Active
Last Updated:
About Ishan Drugs & Pharma Private Limited

Ishan Drugs & Pharma Private Limited, a active private limited company, was established on 04 January 2019 in New Delhi, Delhi, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299DL2019PTC343844. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Nirmala Kumari (Director), Pragya Bharti (Director). Its latest AGM occurred on 19 September 2022, with the balance sheet filed on 31 March 2022. It is based at E-2/49, Basement Floor, Kh.No.19/17, Gali No.29, Chanakya Place, Pankha Road,, New Delhi, Delhi, 110059.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299DL2019PTC343844

  • Registration Number

    343844

  • Incorporation Date

    04 January 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 1 Month
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** %
  • Profit Growth **** 88.82%
  • Ebitda **** 95.49%
  • Net Worth -28.12%
  • Total Assets -6.43%
Company report

Ishan Drugs & Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ishan Drugs & Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ishan Drugs & Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nirmala Kumari Director 04 Jan 2019 Current
Pragya Bharti Director 04 Jan 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ishan Drugs & Pharma.

Ishan Drugs & Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 88.82% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.12%.

Ishan Drugs & Pharma revenue growth over time
Ishan Drugs & Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
-6.43%
*******
*******
*******
*******
Profit or Loss
*******
88.82%
*******
*******
*******
*******
Net Worth
*******
-28.12%
*******
*******
*******
*******
EBITDA
*******
95.49%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ishan Drugs & Pharma?

Unlock access to Ishan Drugs & Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ishan Drugs & Pharma?

Unlock and access historical data on people associated with Ishan Drugs & Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ishan Drugs & Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishan Drugs & Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ishan Drugs & Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ishan Drugs & Pharma Private Limited last Annual general meeting of members was held on 19 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Ishan Drugs & Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi Ii. was completed.

  • Director Appointment

    Progress on Nirmala Kumari was appointed as a Director was appointed as a Director on 04 Jan 2019 & has been associated with this company since 7 years 1 month . was documented.

  • Director Appointment

    Pragya Bharti was appointed as a Director was appointed as a Director on 04 Jan 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Company Incorporation

    Progress on Ishan Drugs & Pharma Private Limited was registered on 04 Jan 2019 with Roc Delhi Ii & aged 7 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ishan Drugs & Pharma Private Limited?

The CIN of Ishan Drugs & Pharma Private Limited is U24299DL2019PTC343844.

Where is Ishan Drugs & Pharma Private Limited headquartered?

Ishan Drugs & Pharma Private Limited is headquartered at E-2/49, Basement Floor, Kh.No.19/17, Gali No.29, Chanakya Place, Pankha Road,, New Delhi, Delhi, 110059.

When was Ishan Drugs & Pharma Private Limited incorporated?

Ishan Drugs & Pharma Private Limited was incorporated on 04 January 2019.

Who are the current directors of Ishan Drugs & Pharma Private Limited?

The current directors of Ishan Drugs & Pharma Private Limited are

What is the primary industry of Ishan Drugs & Pharma Private Limited?

The primary industry of Ishan Drugs & Pharma Private Limited is Chemicals.

Is Ishan Drugs & Pharma Private Limited a listed company?

Ishan Drugs & Pharma Private Limited is unlisted.

What is the capital structure of Ishan Drugs & Pharma Private Limited?

The authorized capital of Ishan Drugs & Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available